This positive trend for listed supplements and vitamins companies is a surprise.
At the beginning of 2023, the 2 leaders (Blackmore and Swisse) were cautious about the Australian market, both expecting a slowdown, due to the cost of living pressures.
I see 3 possible explanations for the good trend now for EZZ,BIO and VLS :
- they are much smaller companies* than the 2 leaders (ex.Blackmore sales are estimated to be 10x Vita sales),
- EZZ and Bio are still very recent companies,
- the 3 companies benefit from their rapid expansion out of Australia.
* in FY 23, Swisse had global sales of 1 bn AUD vs 37 m AUD for EZZ, 8 m AUD for Biome and 74 m AUD for Vita Life Sciences.
- Forums
- ASX - General
- Healthcare supplement listed companies
Healthcare supplement listed companies, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries